Additionally, enteral administration of recombinant PAFAH or PAF receptor antagonist to neonatal rats resulted in a significant decrease in NEC Caplan et al. (1997;1997) strengthening the concept of functional antagonism of PAFAH in the NEC medicated by PAF. The gene discussed is PCLAF; the disease is necrotizing enterocolitis.